or Try an Advanced Search...

    Technical Analysis for GRI - GRI Bio, Inc.

    Grade Last Price % Change Price Change
    F 1.90 -1.04% -0.02
    GRI closed down 1.04 percent on Monday, July 1, 2024, on 2.02 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical GRI trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Calm After Storm Range Contraction -1.04%
    NR7 Range Contraction -1.04%
    NR7-2 Range Contraction -1.04%
    Narrow Range Bar Range Contraction -1.04%
    Lower Bollinger Band Walk Weakness -1.04%
    Older End-of-Day Signals for GRI ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 8 hours ago
    Down 1% about 8 hours ago
    5x Volume Pace about 9 hours ago
    3x Volume Pace about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    GRI Chart by TradingView
    Basic chart:

    Profile

    GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was incorporated in 2009 and is based in LA Jolla, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Immune System Autoimmunity Liver Disease Natural Killer Cell Lymphocytes T Cell Natural Killer T Cell

    Is GRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 GRI Bio to Present at the 8th Annual IPF Summit
    Jun 28 GRI Bio Announces Closing of $4.0 Million Public Offering
    Jun 27 GRI Bio announces pricing of $4 million public offering
    Jun 27 GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
    Jun 27 GRI Bio Announces Pricing of $4 Million Public Offering
    Jun 20 GRI Bio files to offer shares of common stock
    Jun 14 GRI Bio announces 1-for-13 reverse stock split
    Jun 12 Connect Biopharma Announces New Leadership and Chair of the Board of Directors
    Jun 11 GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference
    May 22 GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs
    See more GRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 441.7049
    52 Week Low 1.71
    Average Volume 113,577
    200-Day Moving Average 43.03
    50-Day Moving Average 4.36
    20-Day Moving Average 2.96
    10-Day Moving Average 2.42
    Average True Range 0.54
    RSI (14) 27.54
    ADX 28.21
    +DI 18.91
    -DI 21.08
    Chandelier Exit (Long, 3 ATRs) 3.20
    Chandelier Exit (Short, 3 ATRs) 3.32
    Upper Bollinger Bands 4.25
    Lower Bollinger Band 1.67
    Percent B (%b) 0.09
    BandWidth 87.39
    MACD Line -0.75
    MACD Signal Line -0.72
    MACD Histogram -0.0302
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.49
    Resistance 3 (R3) 2.55 2.42 2.39
    Resistance 2 (R2) 2.42 2.27 2.39 2.35
    Resistance 1 (R1) 2.16 2.18 2.10 2.10 2.32
    Pivot Point 2.03 2.03 2.00 2.00 2.03
    Support 1 (S1) 1.77 1.88 1.71 1.71 1.48
    Support 2 (S2) 1.64 1.79 1.61 1.45
    Support 3 (S3) 1.38 1.64 1.41
    Support 4 (S4) 1.32